miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway

Figure 5

miR-503 regulated the expression of Nrf2 in myocardial cells; (a) the expression of miR-503; (b) the gene expression of Nrf2; (c-d) the protein expression of Nrf2; : compared with control, value < 0.05 was considered to be statistically significant; #: compared with mimics, value < 0.05 was considered to be statistically significant.

(a)

(b)

(c)

(d)